Dr. Priya Naidoo

Dr. Priya Naidoo is a reproductive medicine specialist and IVF clinician based at Mediclinic Cape Town, one of Cape Town's leading private hospitals and home to a fully accredited assisted reproduction unit. With 18 years of experience, she is one of South Africa's most experienced fertility specialists and one of the country's leading advocates for evidence-based reproductive care with a patient-centred approach. Her practice encompasses the full range of fertility investigation and treatment — from initial diagnostic workup and ovulation induction to complex IVF with ICSI, donor programmes, preimplantation genetic testing, and fertility preservation for patients facing cancer treatment or elective egg freezing. She trained at the University of KwaZulu-Natal and the University of Cape Town, and holds both South African specialist credentials (FCOG(SA)) and the UK MRCOG, as well as an advanced diploma from the European Society of Human Reproduction and Embryology (ESHRE) — a combination that positions her at the intersection of African and European fertility practice standards. She is a recognised international patient destination, with patients travelling from Zimbabwe, Namibia, Botswana, Mozambique, Kenya, and Nigeria as well as from the UK, Australia, and the Middle East for IVF treatment in Cape Town. She is trilingual in English, Tamil, and Zulu, giving her a warm and culturally sensitive rapport with South Africa's diverse patient communities.

Dr. Naidoo completed her MBChB at the University of KwaZulu-Natal and undertook specialist training in Obstetrics and Gynaecology, attaining FCOG(SA) before subspecialising in reproductive medicine. She completed a Certificate in Reproductive Medicine at the University of Cape Town's fertility training programme and subsequently passed the MRCOG examination of the Royal College of Obstetricians and Gynaecologists in the United Kingdom, broadening her international credential base. She holds an Advanced Diploma in Reproductive Endocrinology and Infertility from the European Society of Human Reproduction and Embryology (ESHRE), which required completion of structured training in reproductive endocrinology, ovarian stimulation, embryology, and assisted reproductive technology. She has undertaken clinical observation visits to fertility centres in London, Amsterdam, and Barcelona and regularly attends ESHRE's annual congress.

Dr. Naidoo's IVF practice at Mediclinic Cape Town's fertility unit covers the complete spectrum of assisted reproductive technology. She performs controlled ovarian stimulation and egg retrieval for IVF and ICSI cycles, fresh and frozen embryo transfer, blastocyst biopsy for preimplantation genetic testing (PGT-A for aneuploidy screening and PGT-M for monogenic disease), and gamete donation coordination. She offers fertility preservation including egg freezing for patients undergoing cancer treatment (oncofertility) and for social egg freezing. Her PCOS management integrates ovulation induction with letrozole and FSH, lifestyle intervention, and IVF where indicated. She manages diminished ovarian reserve with optimised stimulation protocols and, where appropriate, donor egg IVF. Her recurrent pregnancy loss workup includes chromosomal analysis, thrombophilia screening, uterine assessment, and immunological evaluation. She performs diagnostic and operative hysteroscopy for uterine septum, polyp, and fibroid management, and laparoscopic surgery for endometriosis in the fertility context.

Dr. Naidoo has published in Human Reproduction, the Journal of Assisted Reproduction and Genetics, and the South African Medical Journal. Her research focuses on PCOS phenotyping in South African women of Indian and Black African ancestry — a study that demonstrated phenotypic differences not captured by standard Rotterdam criteria — and on IVF outcomes in patients with diminished ovarian reserve at her Cape Town unit. She has contributed to SASREG's registry of IVF outcomes in South Africa and has presented at ESHRE annual congresses on oncofertility access in the African context. She is currently a co-investigator on a study examining the cost-effectiveness of PGT-A in South African IVF practice, coordinated through the University of Cape Town.

Dr. Naidoo has built a deliberately international practice, attracting fertility patients from across Africa and the world who are drawn to Cape Town's combination of world-class IVF laboratory facilities, ESHRE-standard clinical protocols, and costs significantly below those in the UK, Australia, or the United States. She is experienced in managing every aspect of the cross-border fertility patient journey: remote initial consultation by video for preliminary assessment, tailored stimulation protocol planning, coordination of treatment timing to fit international travel schedules, transfer of frozen embryos for patients who prefer to freeze in Cape Town and transfer locally, and ongoing remote monitoring support. Her practice has English as the working language for all international communications, and she provides written treatment plans and cycle summaries suitable for patients presenting to fertility specialists in their home countries. Mediclinic Cape Town's international patient coordinator handles travel, accommodation, and logistics for patients flying in specifically for IVF treatment.

Dr. Naidoo has been recognised by SASREG with the society's clinical innovation award for her work on PCOS phenotyping in South African women and her contribution to developing the society's clinical guidelines on ovulation induction. ESHRE has recognised her as an active contributing member and has invited her to present research at its annual congress. The University of Cape Town has acknowledged her postgraduate supervision and her contribution to reproductive medicine training in South Africa. She was named in Acumen magazine's list of South Africa's leading medical specialists and is regularly cited in South African media as an expert voice on fertility and reproductive health for women across the African continent.